T1	Participants 209 259	patients with acute severe pulmonary embolism (PE)
T2	Participants 0 14	The UKEP study
T3	Participants 951 1106	133 patients were included in this trial: two patients died before treatment and two were excluded retrospectively, leaving 129 patients for final analysis
